Keeping Up with Innovation: Institutional Review Boards and Therapeutic Specialization

Provided By:

Schulman IRB

July 14, 2017

The therapeutic landscape is shifting rapidly, and it’s becoming more and more important for those involved in overseeing clinical research to be familiar with the latest breakthroughs and treatments. Increasing sophistication in the design, conduct, and analysis of clinical research complicates the review process, as IRBs must possess the expertise to understand the underlying science well enough to ascertain the risk/benefit ratio appropriately.

Post a Comment

You must be logged in to post a Comment.

FEEDBACK